Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
FDG PET to Assess Therapeutic Response in Patients With Bone Dominant Metastatic Breast Cancer, FEATURE
NCT Number:
NCT04316117
Phase:
II
Protocol Type:
Diagnostic
Age Group:
Adults
Disease Sites:
Breast
Study Objectives:
This phase II trial studies how well FDG-PET/CT works in assessing the response of patients with breast cancer that has spread to the bones or mostly to the bones (bone-dominant metastatic breast cancer). Diagnostic procedures, such as FDG-PET/CT, may work better in measuring breast cancer activity before and after treatment compared to other standard imaging tests.
Study Documents
(MUSC NetID required for document access)